Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Reported updated data from ongoing Phase 1b trial in kidney transplantation demonstrating tegoprubart treatment successfully prevented kidney transplant rejection and was generally safe and.
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 65,300 shares, a growth of 147.3% from the November 30th total of 26,400 shares. Based on an average daily volume of 97,400 shares, […]
Petauri™ Elects William Fleming and James Robinson to Its Board of Directors insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.